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Abstract 
Background: Even if the use of medicinal plants has a long tradition in Ethiopia, little is known about which 
medicinal plants are concomitantly used with which conventional medicines, since patients’ disclosure to their 
treating physicians is low. The concomitant use of medicinal plants and conventional medicines may increase the 
risk of unwanted interactions, unexpected toxicities and possible under-treatment. The aim of this study was to 
identify plants concomitantly used with conventional medicines by hypertensive patients.  
Methods: A total of 365 patients and 17 healers were surveyed to identify medicinal plants commonly used by 
hypertensive patients. In addition, patients’ charts were reviewed to identify if they had any co-morbid conditions 
or history of taking medicinal plants. Descriptive statistics were used for the analysis. 
Results: Of 365 hypertensive patients, 171(46.8%) reported having co-morbidities, mainly 
hypercholesterolemia(28, 7.7%), diabetes mellitus(38, 4.9%) and asthma (12, 3.3%). While the majority (319, 
87.4%) of patients preferred modern medicines for the management of their hypertension, some preferred taking 
holy water (24, 6.69%) and using medicinal plants (20,5.5%). The concomitant use of medicinal plants and 
conventional medicines was practiced by just under half of the patients (171, 46.8%). Hydrochlorothiazide, 
enalapril, nifedipine, amlodipine, atenolol and aspirin were the most commonly used conventional medicines. 
Moringa (Moringa stenopetala), damakase (OcimumlamiifoliumHochst.), haregresa (ZehneriascabraSond.) and 
thyme(Thymus serrulatus)were the most commonly used plants. However, none of these medicinal plants were 
standardized in terms of the dose, frequency, duration or method of preparation. 
Conclusions: Conventional medicine was the initial primary treatment choice for hypertensive patients. However, 
a high tendency of using medicinal plants concomitantly was observed due to the side-effects of conventional 
medicines, patients’ curiosity to try medicinal plants and the desire to achieve better blood pressure control. 
[Ethiop. J. Health Dev. 2019; 33(4):239-249] 
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Introduction 
The use of medicinal plants for therapeutic purposes is 
as old as human kind. The concomitant intake of 
medicinal plants with prescribed medications is 
increasingly common among patients with chronic 
diseases such as hypertension (1,2). The main reason 
for the co-use of medicinal plants with conventional 
medicine is the perception that medicinal plants are 
entirely safe, since they are derived from natural 
sources (3). Other reasons are the assumption that 
medicinal plants are relatively accessible, affordable 
and efficacious compared to conventional medicines 
(4-6),dissatisfaction with conventional treatment, past 
good experiences of taking medicinal plants, as well as 
family traditions (7). 
 
The co-use of conventional anti-hypertensive 
medicines and medicinal plants is becoming a major 
safety concern due to a rise in hypertension prevalence, 
aging populations, intrinsic pharmacokinetic and 
pharmacodynamics interactions, unsupervised self-
administration (8) and lack of adequate knowledge 
about the phytochemicals and pharmacological 
properties of medicinal plants (6,7). The low tendency 
of patients to disclose to their treating physicians and 
pharmacists that they are using medicinal plants, either  
 
alone or in combination with conventional medicine, 
makes the matter worse(2,6,9-11), since co-use may 
increase the risk of unwanted interactions, unexpected 
toxicities and possible under-treatment, either by 
mimicking, decreasing, or increasing the action of 
conventional medicines (12).  
 
Moreover, the absence of readily available clinical and 
pharmacological information related to drug-herb 
interactions, particularly for indigenous medicinal 
plants commonly used by hypertensive patients, makes 
doctors and pharmacists oblivious to their patients’ use 
of medicinal plants. This may result in adverse drug-
herb interactions (1). Recognizing adverse effects 
related to medicinal plant use in health facilities is not 
easy and is often under-reported (13). Overtime, 
patients may substitute conventional therapies with 
medicinal plants without informing their doctors (2). In 
Ethiopia, despite the increase in health service 
coverage, a substantial number of people still rely on 
herbal medicines to meet their healthcare needs 
(14,15). A study conducted among hypertensive 
patients in Gondar revealed that 75.3% of patients co-
used medicinal plants and conventional medicines (5). 
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 Moreover, some traditional healers reported providing 
conventional medicine along with herbal preparations 
for their patients (16). 
 
In the light of these facts, the potential herb-drug 
interaction of commonly used medicinal plants with 
prescribed conventional medicines still needs to be 
explored. The aim of this study was to identify plants 




Study design: A survey was conducted in four regions 
and one city administration from May to June2017. 
 
Study areas: The present study was conducted in five 
hospitals selected in Bahir Dar, Adama, Hawassa and 
Mekele in four regional states (Amhara, Oromia, 
SNNP and Tigray) and one city administration (Addis 
Ababa). 
 
Sampling and sample size: The five hospitals were 
selected purposively based on the volume of patients 
and the type of services they render.  
 
Using an interviewer-administered questionnaire, the 
survey was conducted among all hypertensive patients 
aged 18 years or older who volunteered to be 
interviewed and visited the outpatient department 
during the study period. 
 
Data collection tools: The questionnaire had two parts: 
Part I: Socio-demographic characteristics; and Part II: 
Conventional and herbal medicine use. In the first part, 
respondents were asked about their age, address, 
religion, education status, occupation, average income, 
and household size. In the second part, they were asked 
about the duration of being diagnosed for hypertension, 
choice of first treatment, the use of conventional and 
herbal medicines, reasons for taking/not taking herbal 
medicines, source of information, history of 
discontinuing medication, and any discussions they 
have had with their physician or pharmacist about 
herbal medicines. The questionnaire was prepared in 
English based on previous literature and studies 
(17,18), and was translated into three local languages 
(Amharic, Oromifa, and Tigrigna) to collect the 
required information from respondents.  
 
In addition, a self-administered questionnaire was used 
for healers to identify the different medicinal plants 
they use for the treatment of hypertension and to assess 
patients’ history of plant use. The data abstraction form 
was also used to collect information from the patients’ 
charts regarding any recorded herbal medicines used, 
in order to identify co-morbid conditions and the types 
of medicine taken by patients. Data were collected by 
10 trained pharmacists, all of whom were based around 
the selected hospitals and who could speak the local 
language used in the area. 
 
The questionnaire was pretested in a general hospital 
not included the study and was amended accordingly. 
Adequate training was given to all data collectors 
regarding the data collection tool and the approach they 
should follow during interviews. 
 
The data were coded, entered, cleaned and analyzed 
using SPSS version 20. Descriptive statistics were used 
to summarize results in the form of tables and graphs. 
 
Ethical considerations 
Ethical clearance was obtained from the Institutional 
Review Board (IRB) of the College of Health Sciences, 
Addis Ababa University. In addition, permission was 
secured from directors of selected hospitals and 
administrators in the respective kebeles. Written 
consent was secured from each participant after 
explaining the aims of the study. Participants were 
assured that no personal identifiers would be used and 
the collected data would be analyzed in aggregate. 
 
Results  
Socio-demographic characteristics of participants: A 
total of 365 patients participated in this study. The 
majority were females (203, 55.6%), aged above 40 
years (306, 84.8%), married (213, 58.4%) and urban 
dwellers (298,81.6%). In terms of education, the vast 
majority (164, 72.4%) had no formal education or had 
completed a low level of formal education. 
Respondents’ earnings ranged from ETB 100 to ETB 
20,000 per month, with a median income of ETB 1,550 
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Table 1: Socio-demographic characteristics of adult patients with hypertension, May-June 2017 (n=365) 
Variables (n=365) Frequency Percentage 
Gender   
Male 162 44.4 
Female 203 55.6 
Age (in years)* ††   
≤40 55 15.1 
41-50 80 21.9 
51-60  105 28.8 
>60 121 33.2 
Region    
Addis Ababa 79 21.6 
Amhara  85 23.3 
Oromia 98 26.8 
Tigray 42 11.5 
SNNP 61 16.7 
Residential area   
Urban 298 81.6 
Rural  67 18.4 
Religion    
Orthodox Christian  254 69.6 
Muslim 74 20.3 
Protestant Christian 31 8.5 
Others 6 1.6 
Marital status††   
Married 213 58.4 
Single  23 6.3 
Divorced 11 3 
Widowed 33 9 
Educational status    
Low education† 186 51.0 
Primary level                    78 21.4 
Secondary level                                                 43 11.8 
Post-secondary education                           58 15.9 
Occupational status ††   
Housewife  124 34 
Salaried employment  34 9.3 
Self-employed (trading, farming) 88 24.1 
Unemployed or retired 62 17 
Others 10 2.7 
*Mean±SD=55.86±13.4; range=20 to 91; median income= ETB1,550 birr (IQR=3,100), 
†Either cannot read or write or has basic reading/writing skills. 
††missing data 
 
Clinical conditions and treatment of patients with 
hypertension: Of the 365 hypertensive patients 
interviewed, 171(46.8%) reported having co-
morbidities, mainly hypercholesterolemia (28, 7.7%), 
diabetes mellitus (38, 4.9%) and asthma (12, 3.3%). On 
average, they had lived with hypertension for 6.0 years 
(SD±5.8 years, range= 1 month to40years). 
 
Most (319, 87.4%) of the hypertension patients 
preferred conventional (modern) medicines for the 
management of their hypertension. Holy water and 
herbal medicines were used by 24(6.69%) and 20 
(5.5%) patients, respectively. 
 
As Figure 1 shows, 74.5% of the respondents were 
taking two or more medications concurrently for an 












242     Ethiop. J. Health Dev 
 







Figure1: Number of conventional medicines taken by hypertensive patients, May-June2017 (n=365) 
 
Hydrochlorothiazide, enalapril, nifedipine and amlodipine were observed to be the most commonly prescribed 
anti-hypertensive medications (Table 2). 
 
Table 2: Frequently prescribed conventional medicines for hypertensive patients, May-June 2017(n=354) 
Agents Class of medication Drugs n % 
Primary anti-hypertensive 
agents (56.4%) 
Thiazide diuretics Hydrochlorothiazide 177 20.8% 
ACE inhibitors Enalapril 173 20.3% 
Calcium channel blockers 
Nifedipine 73 8.6% 
Amlodipine 57 6.7% 
Secondary anti-hypertensive 
agents (10.1%) 
Loop diuretics Furosemide 25 2.9% 
Beta blockers 
Atenolol 52 6.1% 
Metoprolol 9 1.1% 
Antiplatelets (5.5%) NSAIDS Aspirin 47 5.5% 
Anti-diabetics (10.3%) 
Biguanide Metformin 39 4.6% 
Sulfonylureas Glibenclamide 28 3.3% 
Insulin 
Insulin 10 1.2% 
NPH insulin 10 1.2% 
Cholesterol-lowering 
medications (8.7%) Statins 
Atorvastatin 22 2.6% 
Simvastatin 19 2.2% 
Lovastatin 15 1.8% 
Anti-depressants (2.1%) Tricyclic anti-depressants Amitriptyline 18 2.1% 
Antiulcer (1.1%) Proton pump inhibitors Omeprazole 9 1.1% 
Others (7.9%)  Others 68 7.9% 
 
Almost half of the hypertensive patients (171, 46.8%) 
reported having used medicinal plants either to treat 
their illness or maintain their health. They also 
obtained medicinal plant-related information mainly 
from their friends (63, 17.5%), physicians (34, 9.3%), 
the mass media (e.g. newspaper/internet/TV) and 
elders (5, 1.4%). However, one third of the 
patients(113, 31%) were not aware of the potential 
health risk of using un standardized medicinal plants 
(in dose, frequency and duration) and when co-used 
with the conventional medicine. 
 
On the other hand, 218(59.7%) patients reported to 
have never used medicinal plants for the management 
of their hypertension. Their main reasons were 
satisfaction with the treatment outcome of conventional 
medicine (69, 31.7%) and perceived safety issues of 
taking medicinal plants (56, 25.7%). 
 
One quarter of hypertensive patients (98, 26.8%) used 
both conventional and medicinal plants. Their reasons 
were to have better control of blood pressure (73, 
20%), or to experiment (8, 2.1%) with medicinal plants 
to see if they have fewer side effects compared to using 
ant-hypertensive medicines. A few also used both, 
stating that using medicinal plants alongside 
conventional medicines would have no side effects. 
 
Despite the fact that a sizable number of patients (98) 
reported concomitant use of medicinal plants and 
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conventional medicines, only 12 (3.2%) patients 
disclosed using both to their treating physicians or 
pharmacists. Of these, half of them said that they were 
encouraged to continue taking both. Ten percent (33) 
of the patients discontinued taking conventional 
medicines after they had started taking medicinal 
plants. 
As shown in Table 3, 24 medicinal plants were 
identified by hypertensive patients. Of these, 17 were 
used to manage hypertension. Moringa (Moringa 
stenopetala) (76 informants) was the most commonly 
reported plant, followed by damakase 
(Ocimumlamiifolium) (29), haregresa (Zehneriascabra) 
(15) and thyme (Thymus schimperi) (15). 
 






Scientific name Family Part(s) used Number of 
informants 
 
Shiferaw Moringa Moringastenopetala (Baker 
f.) Cufod.  
Moringaceae Seed (11) and 
leaf (65) 
76 
Damakase*  OcimumlamiifoliumHochst. Lamiaceae Leaf (29) 29 
Haregresa  ZehneriascabraSond. Cucurbitaceae Leaf (15) 15 





Garlic Allium sativum L. Alliaceae Seed (7) 7 
Abish Fenugreek Trigonellafoenum-graecum 
L. 
Fabaceae Seed (5) 5 
Tikurazimud Black cumin Nigella sativa L. Ranunculaceae Seed (5) 5 
Taliba Flaxseed LinumusitatissimumL. Linaceae Seed (4) 4 
Tenadam* Rue Rutachalapensis L. Rutaceae Seed (1) and 
leaf (3) 
4 
Gibto White lupin Lupinus termisForssk Fabaceae Seed (3) 3 
Kerefa Cinnamon Cinnamomumverum J. Presl Lauraceae Root (3) 3 
Bahir zaf* Eucalyptus Eucalyptus globules Labill Myrtaceae Leaf (2) 2 
Kosso*  Hageniaabyssinica(Bruce) 
J.F.Gmel. 
Rosaceae Seed (2) 2 
Tunjut  Otostegia integrifolia Benth.  Lamiaceae Stem(2) 2 
Zinjibil Ginger Zingiberofficinale Roscoe  Zingiberaceae Root (2) 2 
Armagusa  AjugaintegrifoliaBuch. Ham.  Lamiaceae Leaf (1) 1 
Buna* Coffee Coffea Arabica L. Lamiaceae Seed (1) 1 
Dimbilal Coriander 
 
Coriandrum sativumL. Apiaceae Seed (1) 1 
Ensilal Fennel Foeniculumvulgare Mill. Apiaceae Leaf (1) 1 
Girawa  VernoniaamygdalinaDelile Asteraceae Leaf (1) 1 
Khat Khat Catha edulis Forsk Celastraceae Leaf (1) 1 
Lomi* Lemon Citrus limon(L.) Osbeck Rutaceae Seed (1) 1 




Guava PsidiumguajavaL. Myrtaceae Leaf (1) 1 
* Shows herbs used by hypertensive patients for other comorbidities they have e.g. diabetes, ‘michi’, cough 
etc. 
Leaves (70%) and seeds (26%) were the most 
commonly used morphological parts.  
 
However, large inconsistencies in dose, frequency, 
duration and preparation techniques of medicinal plants 
were observed in this study. For instance, Moringa 
stenopetala, the plant most widely used by the patients 
for the management of hypertension, was taken in 33 
different ways (Table 4). While 14.8% of the 
respondents used the seeds, 85.2% used the leaves. 
Respondents also reported taking the required amount 
of the seed/leaf using a spoon, a coffee cup or a glass, 
all of which could vary from household to household. 
The frequency of administration also ranged from 
taking the medicinal plants occasionally to three times 
per day. Similarly, the duration varied greatly – some 
were taking it when needed or available, and others 
were taking it once or for different periods, up to a 
year, or on a lifelong basis. There were also patients 
who did not know how much and for how long to take 
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Table4: Inconsistencies in dose, frequency and duration of Moringa stenopetalause by hypertensive 




Dose Frequency Duration 
Seeds 
 
1 coffee cup Three times a day When available 
1 glass Once a day As needed 
1spoonful Once a day For three months 
1 spoonful Occasionally For a month 
1 spoonful Once a day For a month 
1 spoonful Three times a day When available 




1 coffee cup Once a day When available 
1 coffee cup Once a day For a year 
1 coffee cup Once a day When available 
1 glass Once a day Lifelong 
1 glass Once a day When available 
1 glass Once a day Until improved  
1 glass Once a day For three months 
1 glass Once a day For two months 
1 glass Once a day For a month 
1 glass Once a day Only once 
1 glass Once a day Undefined 
1 glass Twice a day For a month 
1 glass Three times a day Lifelong  
1 glass Three times a day For a year 
1 glass occasionally When available 
1 glass Occasionally Undefined 
1 glass Undefined Undefined 
Undefined Occasionally Until improved 
Undefined Once a day Lifelong 
1spoonful Once a day For a year 
1 spoonful Once a day Until improved 
1 spoonful Once a day Lifelong 
1 spoonful Occasionally For three days 
Rub the leaf 
vigorously and 
express the liquid 
Occasionally Until improved 
Undefined Occasionally Undefined 
Undefined Undefined Undefined 
Undefined Once a day Only once 
 
Respondents reported using different preparation 
techniques in order to take medicinal plants as a 
treatment (Figure2). Many of them would dry and 
shred the different parts of the medicinal plants and eat 
them as food (48.6%);some mixed the powdered herbs 
with coffee and drank them (9.2%);others ate the 
leaves and seeds as food. Boiling the leaves and 
inhaling the vapor was also reported (5.9%). 
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Figure 2: Commonly used preparation and adminstration techniques of medicinal plants used by 
hypertensive patients in Ethiopia, May-June2017 
 
After using medicinal plants, 150 (41.1%) respondents 
said their health condition had improved, while the rest 
(211, 57.9%) reported no change or progress in their 
health condition.  
 
Herb-drug interaction from healers’ perspectives: 
Seventeen traditional healers agreed to participate in 
this study. Most of them were males (16/17), and 
Orthodox Christians (10/17). In terms of education, six 
of the 17 attended religious schools; the rest attended 
secondary school or university.  
 
As Figure 3 below shows, healers reported that they 
obtained their knowledge from their families (15/17), 
religious institutions (6/17), or from other healers 
(4/17), friends (3), and as a gift from God (2), with 
most healers mentioning more than one source. At the 
time of the survey, almost all (15/17) healers were 
working full time. On average, a healer treated 23 
patients (SD= 24.3; range= 3 to 70 patients per week). 
 
Figure 3: Healers’ source of knowledge for their traditional medicine practice (n=17), May-June 2017 
 
Of the 17 healers, 14 were willing to provide 
information regarding the different medicinal plants 
they used for the treatment of hypertension. On 
average, a healer disclosed 1.6 medicinal plants 
(SD=1.081) ranging from 1 to 5 (Table 5). They also 
reported getting the knowledge of practicing traditional 
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Yes No Don’t know 
Amera  Plumbagozeylanica L. Plumbaginaceae 1 Root   1   
Armagusa  
AjugaintegrifoliaBuch. 
Ham.  Lamiaceae 2 Leaves 1   1 
Damakase  OcimumlamiifoliumHochst. Lamiaceae 2 Leaves 1 1   
Dimbilal Coriander CoriandrumsativumL. Apiaceae 1 Fruits   1   
Gibto White lupin LupinusalbusL.  Fabaceae 2 Fruits 2     
Kerero  
Acokantheraschimperi 
(A.DC.) Schweinf. Apocynaceae 1 Leaves 1     
Koshim   Dovyalisabyssinica(A.Rich.) Warburg Flacourtiaceae 1 Fruits   1   
Mekmeko   Rumexabyssinicus Jacq.   Polygonaceae 1 Root   1   
Shiferaw Moringa Moringa stenopetala (Baker f.) Cufod.  Moringaceae 3 
Leaves   2   
Fruits   1   
Telba Flaxseed Linumusitatissimum L.  Linaceae 1 Root   1   
Tenadam Rue Ruta chalapensis L. Rutaceae 2 Leaves 2     
Tossign Thyme Thymus schimperiRonniger Lamiaceae 1 Root   1   
Tut astil  
AjugaintegrifoliaBuch.-
Ham. ex D.Don Lamiaceae 1 Root   1   
Werkbemeda   Cocciniagrandis (L.) Voigt Cucurbitaceae 1 Root   1   
 
Discussion 
Our study revealed that patients preferred conventional 
medicine as their first choice for the management of 
hypertension, but many of them used also medicinal 
plants either to treat their illness or maintain their 
health. However, they lacked knowledge about the 
possible health risks of using medicinal plants alone or 
concomitantly with conventional medicine. Moringa, 
damakase, haregresa, thyme, garlic and fenugreek were 
found to be the most commonly used medicinal plants 
among hypertensive patients. 
 
Ethnobotanic studies conducted in Ethiopia also 
reported anti-hypertensive effects of moringa 
(Moringastenopetala), thyme (Thymus serrulatus and 
Thymus schimperi), dokma (Syzygiumguineense), white 
lupin (Lupinusalbus), digita (Calpurniaaurea) and 
armagusa (Ajugaremota)(20,21).  
 
Some herbs were reported by both patients and healers 
to have anti-hypertensive properties. These were: 
armagusa, damakase, white lupin, moringa, flaxseed, 
rue and thyme. In vivo studies conducted in rats 
revealed that crude extracts of moringa (21), thyme 
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(22) and armagusa had anti-hypertensive and diuretic 
activities (20).The seeds of white lupin were also used 
for the preparation of local alcohol in northwestern 
Ethiopia, which is claimed to be helpful in controlling 
hypertension. In white lupin, the relatively high content 
of arginine, a precursor of the nitrogen oxide synthesis, 
probably has a blood lowering effect (23). 
 
Commonly co-used and interacting medicinal plants 
among patients who had a history of hypertension and 
other co-morbidities are: St John’s wort (for 
depression), bee pollen granules (for general 
wellbeing), prickly pear cactus (for diabetes), arejin 
and daiokanzoto (for chronic allergic rhinitis and 
constipation),and fenugreek (for liver disease and to 
stimulate digestion) (1).  
 
Possible interactions between commonly used 
conventional anti-hypertensive medicines (such as 
hydrochlorothiazide, enalapril, nifedipine, amlodipine, 
atenolol and aspirin) and medicinal plants(including 
moringa, damakase, haregresa and tossign) were 
searched for in the literature, but no interactions were 
found.  
 
However, a review of patients who had a history of 
hypertension and other co-morbidities taking herbs and 
using prescribed medications showed that the 
interaction between St John’s wort and warfarin caused 
upper gastrointestinal bleeding and increased 
the international normalized ratio (INR). While the co-
use of bee pollen granules’ interaction with warfarin 
also elevated the INR level, prickly pear cactus 
interaction with glipizide caused hypoglycemia. Those 
patients who combined arejin and daiokanzo developed 
mild anemia, liver dysfunction, mildly elevated 
creatine kinase (CK) level, and severe hypokalemia 
and hypochloremia (1). 
 
Even though the present study showed a high usage of 
medicinal plants among hypertensive patients, most 
biomedical practitioners do not usually ask their 
patients whether they take medicinal plants. Patients’ 
disclosure to their treating physicians regarding their 
concomitant use is also very low. For instance, in 
South Africa, among NCD patients who took 
conventional medicine to manage hypertension, 30% 
were simultaneously using medicinal plants (4). In 
another study conducted in rural communities in South 
Africa, 31 of 50 people who had been diagnosed with 
hypertension were supplementing their prescribed 
hypertension drugs with medicinal plants without 
notifying their doctors (2). Our study showed that 
documenting the use of medicinal plants in patient 
medical charts was also rare. 
 
Appreciating cultural background and the personal 
beliefs of patients, being non-judgmental and making 
patients comfortable to freely tell their practice to 
physicians could improve the situation (10,19,24) and 
may help physicians and other health professionals to 
associate the potential effects of medicinal plants and 
conventional medicine use with therapeutic outcomes. 
 
Our findings show that there is lack of standardization 
in the collection, handling, processing and production 
of medicinal plants; gaps in confirming the identity, 
quality and purity of the medicinal plants; and an 
absence of optimization in dose, frequency and 
duration of taking medicinal plants, which corroborate 
the findings of other studies (25,26). In addition, the 
volume held by measuring cups and spoons used 
should also be specified, rather than relying on this 
information from patients. Pre-formulated and ready-
to-be-dispensed medicinal plants and plant parts should 
also be checked to ascertain if they are adulterated with 
conventional medicine, and if the compounds are being 
prepared in a hygienic environment, meeting the 
criteria of the regulatory authority. Failure to do so 
may endanger the public health. 
 
Limitations of the study 
Our study reported various medicinal plants used by 
hypertensive patients and healers. However, collecting 
samples of some reported plants was not possible. In 
addition, attempts made to check the interaction 
between commonly used anti-hypertensive 
conventional medicines and medicinal plants on the 
internet and Medscape drug interaction checker did not 
provide much information. The second phase of the 
study, including extraction of the herbs and testing 
potential interactions, may provide clinically important 
information. Recall bias also needs to be considered to 




Hypertensive patients in Ethiopia resort to 
conventional medicine as a primary treatment option. 
They also commonly use medicinal plants such as 
moringa (Moringastenopetala), damakase 
(OcimumlamiifoliumHochst.), haregresa 
(ZehneriascabraSond.), thyme (Thymus serrulatus) 
nechshinkurt (Allium sativum L.), fenugreek 
(Trigonellafoenum-graecum L.), armagusa 
(AjugaintegrifoliaBuch. Ham.),gibto (Lupinusalbus) 
and rue (Rutachalapensis L.) alone or in combination 
with conventional medicine. However, none of the 
medicinal plants were standardized in dose, frequency, 
duration or method of preparation. More research is 
necessary to assess the pharmacological effect of the 
reported herbs and their interaction with conventional 
medicine to prevent therapeutic failure and toxicity 
among hypertensive patients and to establish guidelines 
for concomitant use, and to prepare a manual for 
physicians (and guidelines for patients) to make 
informed decisions. Training should be given to healers 
and users on how to extract and prepare different 
medications in a hygienic environment. The type of 
medicines that healers dispense should be identified 
and controlled by the regulatory authority so as to 
protect the public from health risks. 
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